This course explains how to evaluate the health of the gastrointestinal tract and the micriobiota, their relationship to the brain and their impact on many common health disorders. You will learn brain rehabilitation strategies in addition to dietary, nutritional, and lifestyle factors that influence the gut-brain-body relationship.
The last decade of research has focused on the gut microbiome, the gut-brain axis, and gut health in general. Disruption in these pathways can lead to chronic gastrointestinal issues, depression, changes in cognitive function, chronic autoimmune and inflammatory disorders, and various types of brain-based disorders.
Course description
This course will provide an extensive literature review of the gastrointestinal systems and how it impacts, the brain, the immune system the cardiovascular system, and other systems of the body. An evidence-based model incorporating diet, nutrition, and lifestyle medicine will be presented. A clinical step-by-step approach will be presented addressing every major target site of gastrointestinal dysfunction. Clinicians will be provided with clinically applicable models to evaluate and manage complex gastrointestinal disorders at the end of this course.
Learning objectives
- Understand the relationships between the gut and the brain, the immune system, the cardiovascular system, and other systems of the body.
- Review the literature on the the impact of the GI tract and human health
- Review of clinical diseases associated with gastrointestinal dysfunction
- Understand the clinical concepts gastrointestinal messenger pathways that impact human physiology
- Learn how to identify disruption of the gastrointestinal tract with the history and exam
- Learn diet, nutrition and lifestyle approaches to support brain-gut axis dysfunction
- Learn laboratory markers to assess the gastrointestinal status
Pricing
Standard Registration | On demand access | $749 USD |
Student Registration | On demand access | $549 USD |
About the Kharrazian Institute
Dr Datis Kharrazian will be visiting Australia in April 2020 for the 8th BioCeuticals Research Symposium.